Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT00798226
Active, not recruiting Phase 1

Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood

NCT00798226 · tracked via the Priya Life Science Denmark tracker
Sponsor
Copenhagen Studies on Asthma in Childhood
Phase
Phase 1
Started
2008-11-26
Last updated
2026-06-05

Condition(s) studied

AsthmaEczemaAllergy

Investigational drug(s) / intervention(s)

n-3 fatty acidolive oil

n-3 fatty acid: Oral intake of 4 capsules daily from week 24 of gestation to 1 week after delivery

olive oil: Oral intake of 4 capsules (1 g) daily from 24 weeks of gestation to 1 week after delivery

Study summary

The aim of this study is to prevent asthma and allergies in childhood by supplementation with fish oil (n-3 fatty acids) to the mother during pregnancy. Paticipants are mother and children participating in the ABC-(Asthma Begins in Childhood)cohort. Mothers are recruited during pregnancy and receive supplement with n-3 fatty acids or olive oil (placebo) from week 24 of gestation to 1 week after delivery. The child is followed with acute and planned visit at the research unit and diagnosis of disease is done in the research unit according to predefined algorithms.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria (mother): * Pregnant women * Living in Sealand, Denmark * Fluent in Danish Language * Willing to let the newborn child participate in the study Exclusion Criteria (mother): * Participating in other clinical trial

Primary outcome measure(s)

  • Persistent wheeze 0 to 3 years of age — 3 years
    Age at onset of persistent wheeze diagnosed according to predefined algorithm of recurrent troublesome lung symptoms, response to treatment and relapse after withdrawal of treatment

Trial sites (2)

FacilityCityRegionStatus
Copenhagen University Hospital of Copenhagen Gentofte Municipality Gentofte
Næstved Hospital, Pediatric Department Næstved Næstved

More Copenhagen Studies on Asthma in Childhood trials in Denmark

Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms Recruiting
High-dose Vitamin D Supplement for the Prevention of Acute Asthma-like Symptoms in Preschool Children Recruiting
Antibiotic Treatment of Recurrent Episodes of Asthma in Children Active, not recruiting
Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood Active, not recruiting
A Randomized Controlled Trial of Oral Immunotherapy Versus Allergen Avoidance in Children Under 2 Years With Food Allergy Starting soon

Other trials for the same condition

THERMotherapy Against Persistent Bacterial LUNG Infections Starting soon
A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis Recruiting
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma Active, not recruiting
The Effect of Anti-IL17 on Airway Hyperresponsiveness and Resistance Recruiting
Mepolizumab to CRSwNP Through 12 Months - Randomised to FESS and Non-FESS Within the First 2 Weeks Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT00798226 on ClinicalTrials.gov ↗ ← All trials in Denmark